Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Alcohol Clin Exp Res. 2018 Jun 9;42(7):1249–1259. doi: 10.1111/acer.13772

Table 3. Results from Cox Regression Models with Covariates.

Time-to-first drinking day Time-to-first heavy drinking day
OR (95% CI) B (SE) OR (95% CI) B (SE)
Baseline opioid use (misuse=1) 1.266 (0.960, 1.573) 0.24 (.12) 1.384 (1.127, 1.641) 0.33 (.09)**
Baseline drug use (use = 1) 1.234 (1.046, 1.421) 0.21 (.08)** 1.202 (1.040, 1.365) 0.18 (0.07)**
Baseline cannabis use (use=1) 1.289 (1.112, 1.467) 0.25 (.07)** 1.194 (1.030, 1.359) 0.18 (0.07)*
Baseline pain scores 0.985 (0.902, 1.068) -0.02 (.04) 1.044 (0.960, 1.128) 0.04 (.04)
Baseline percent drinking/heavy drinking days 0.997 (0.995, 1.000) -0.003 (.001) 0.997 (0.994, 1.000) -0.003 (.002)
Alcohol dependence severity (ADS) 0.989 (0.980, 0.997) -0.01 (.004)* 1.005 (0.994, 1.015) 0.01 (.006)
Motivation to change (URICA) 0.938 (0.898, 0.979) -0.06 (.02)* 0.944 (0.896, 0.991) -0.06 (.03)*
Temptation (AASE-Withdrawal temptation) 1.025 (0.944, 1.106) 0.03 (.04) 1.021 (0.945, 1.098) 0.02 (.04)
Self-efficacy (AASE-Confidence) 0.910 (0.836, 0.984) -0.09 (.04)* 0.883 (0.797, 0.971) -0.12 (.05)*
Psychiatric distress (BSI GSI) 1.006 (0.999, 1.014) 0.006 (.004) 1.001 (0.991, 1.010) 0.001 (.005)
Therapy (Combined behavioral intervention=1) 0.967 (0.876, 1.058) -0.03 (.05) 0.991 (0.854, 1.128) -0.009 (.07)
Medication (Naltrexone=1) 0.948 (0.860, 1.035) -0.05 (.05) 0.906 (0.826, 0.987) -0.10 (.05)*
Gender (Male=1) 0.753 (0.662, 0.845) -0.28 (.06)** 0.826 (0.728, 0.923) -0.19 (.06)**
Cigarettes per day 1.003 (0.999, 1.008) 0.003 (.02) 1.007 (1.002, 1.012) 0.01 (0.003)*

Note.

*

p<0.05;

**

p<0.01; OR (95% CI)=odds ratio (95% Confidence Interval); B=unstandardized regression coefficient (SE=Standard Error); ADS=Alcohol Dependence Scale; URICA=University of Rhode Island Change Assessment, AASE=Alcohol Abstinence Self-Efficacy Scale; BSI GSI=Brief Symptom Inventory Global Severity Index.